Healthcare AI strategy and organisational readiness
Support for organisations planning AI implementation: priorities, governance, decision-making structures and the capabilities required internally.
For healthcare organisations
Hospitals and clinicians are offered a growing number of AI tools, with uneven evidence and uneven regulatory maturity. We assess these tools with the same scrutiny applied to any other clinical intervention, and report what the evidence does and does not show. Alongside clinical and regulatory work, AiXiliator brings practical understanding of hospital leadership, procurement, public and private healthcare, reimbursement and healthcare decision-making.
Where we help
Support for organisations planning AI implementation: priorities, governance, decision-making structures and the capabilities required internally.
Independent, physician-led assessment of intended purpose, evidence quality, regulatory status and the expected clinical benefit for your patient population.
Study designs that test performance and workflow effects in your own setting, taking account of case mix, data quality, model drift and the limits of vendor-supplied evidence.
Risk assessment, oversight models, escalation logic and monitoring so that clinical responsibility remains clear once a tool is in routine use.
Support for pathway integration, clinician training, internal communication and the follow-up needed to confirm the tool still performs as expected.
Clinically informed requirements and questions for suppliers on intended use, validation populations, monitoring, software updates and post-market obligations.
How we assess
All three founders remain active in clinical practice and academic medicine. Assessments start from patient safety and clinical responsibility, and we will state plainly when a tool is not yet suitable for your setting.